Edesa Biotech, Inc. files 10-K annual report with SEC.
Edesa Biotech, Inc. has recently filed its 10-K/A annual report with the SEC, focusing on its financial performance and operations during the period ending on September 30, 2024. The filing includes important exhibits such as EX-31.3 and EX-31.4, which provide additional insights into the company’s corporate governance and certifications. Investors and stakeholders can access the complete submission text file and other data files through the SEC’s website for a comprehensive understanding of Edesa Biotech’s disclosures.
Attachments:
– Form 10-K/A
– Exhibit 31.3
– Exhibit 31.4
Other relevant information:
– IRS No.: 000000000
– State of Incorp.: A1
– Fiscal Year End: 09/30
– CIK: 0001540159
– SIC: 2834 Pharmaceutical Preparations
Company Website:
– [Edesa Biotech, Inc.](insert company website link here)
Original Filing Link:
– SEC Filing